HDFC Life Insurance Company Ltd.
NSE: HDFCLIFEHDFC Life Insurance Company Ltd.: A 30-second snapshot
HDFC Life Insurance trades at ₹591.85, down 23.04% over 12 months and 27.63% below its 52-week high, with price sitting 14.8% below the 200-DMA. At a trailing PE of 66.87 — the highest among 6 tracked peers — the valuation premium stands alongside an ROE of 11.28% and a quality score of 20/100, both ranking last in the peer group.
P/E
66.9
Forward P/E
48.4
ROE
+11.3%
Debt / Equity
17.46
Profit Margin
+1.9%
Div. Yield
+0.3%
5Y ROE > 15%
0/5
5Y FCF > 0
4/5
Quality
40/100
News
7 headlines · 1 positive · 0 negative
HDFC Life Insurance Company Q1 Results - Mint
Mint
HDFC Life Insurance Company Q4 Results - Mint
Mint
Nirmal Bang Upgrades HDFC Life Insurance Company to Buy from Hold; Price Target is INR700 - marketscreener.com
marketscreener.com
HDFCLIFE allots 1.45 cr equity shares to HDFC Bank - Business Standard
Business Standard
Promoter entities sell Rs 153 crore worth shares in Motilal Oswal block deal; HDFC Life picks up stake - The Economic Times
The Economic Times
Recent context
- ·Nirmal Bang upgraded HDFCLIFE and cited a price target of ₹700, representing the most notable analyst action in the recent news window (source: marketscreener.com, 18 June 2026).
- ·HDFCLIFE allotted 1.45 crore equity shares to HDFC Bank, per a Business Standard report dated 16 June 2026, indicating an ongoing capital/ESOP-related issuance.
- ·Q1 results coverage appeared in Mint on 19 June 2026; the headline was neutral in tone, with no mention of a material earnings surprise in the article metadata.
Strengths
- +FCF was positive in 4 of the tracked years, indicating recurring cash-generation capacity despite the insurance sector's capital intensity.
- +Forward PE of 48.43 is meaningfully below the trailing PE of 66.87, reflecting earnings-growth expectations embedded in consensus estimates.
- +Profit margin of 1.92% is in line with life-insurance industry norms, where net margins are structurally thin due to policyholder reserve accounting.
- +Mean analyst rating of 1.29 across 35 analysts on a 1–5 scale (lower = more constructive) represents one of the larger analyst coverage pools among Indian private insurers.
Weaknesses
- −Trailing PE of 66.87 is the highest of 6 peers; the next-closest peer (Bajaj Finance) trades at 31.65 — HDFCLIFE carries a 111% premium on this metric while ranking last on ROE and quality score.
- −ROE of 11.28% has not crossed 15% in any tracked year and ranks last of 6 peers (range 13.15–17.91%), with a consistency score of 37 out of 100.
- −5-year revenue growth of -17.7% indicates top-line contraction over the tracked period; earnings growth of 4.1% over the same span has not kept pace with the valuation multiple.
- −Price is below both the 50-DMA (₹595.05) and the 200-DMA (₹694.32), and has been down over 23% on a 12-month basis, with 3-month momentum also negative at -6.24%.
Open questions
- ?Does the 66.87 trailing PE reflect a justified growth premium specific to HDFC Life's product mix and distribution reach, or does it represent sector-wide multiple expansion that may compress as rates normalize?
- ?The 5-year revenue contraction of -17.7% contrasts with positive FCF in 4 of those years — what does the reconciliation between top-line and cash-flow trends reveal about the accounting treatment of policyholder liabilities?
- ?HDFCLIFE ranks last of 6 peers on ROE and quality score while commanding the highest PE — how does the competitive positioning in the private life-insurance market explain this gap relative to diversified financials peers?
- ?Given that price has remained below the 200-DMA while analyst consensus has remained constructive, what catalysts — regulatory, macroeconomic, or company-specific — would be necessary to close that divergence?
Peer comparison: Banking
Ranks 6 of 6 on quality| Symbol | Name | P/E | ROE | Quality |
|---|---|---|---|---|
| HDFCLIFE | HDFC Life Insurance Company Ltd.You're viewing | 66.9 | +11.3% | 20 |
| Industry avg | across 5 peers | 22.4 | +15.2% | 47 |
| ICICIBANK | ICICI Bank Ltd. | 18.0 | +16.4% | 64 |
| BAJFINANCE | Bajaj Finance Ltd. | 31.6 | +17.9% | 51 |
| AXISBANK | Axis Bank Ltd. | 16.1 | +13.2% | 50 |
| HDFCBANK | HDFC Bank Ltd. | 17.4 | +13.8% | 47 |
| BAJAJFINSV | Bajaj Finserv Ltd. | 29.0 | +14.6% | 23 |
Technical state
Current price
₹591.85
SMA 50
₹595.05
SMA 200
₹694.32
RSI (14)
54.2 (neutral)
From 52w high
-27.6%
1Y return
-23.0%
3M return
-6.2%
50-DMA
Below
200-DMA
Below
Algorithmic support levels
Algorithmic resistance levels
Risk flags
- highTrailing PE of 66.87 is the highest in the 6-stock peer group by a wide margin; the next-highest peer PE is 31.65 (Bajaj Finance). This premium is not supported by ROE, which at 11.28% ranks last of 6 peers (peer range 13.15–17.91%), or by quality score, which also ranks 6th of 6 at 20 out of 100.
- high5-year revenue growth of -17.7% indicates top-line contraction over the tracked period. ROE has not exceeded 15% in any tracked year (roeYearsAbove15 = 0), consistency score is 37 out of 100, and debt-to-equity of 17.46 carries a rising trend — structural leverage characteristic of life-insurance balance sheets, though elevated even within that context.
- highCurrent price of ₹591.85 is below both the 50-DMA (₹595.05) and the 200-DMA (₹694.32), a gap of 14.8% to the 200-DMA. The stock is down 23.04% over 12 months and 6.24% over 3 months, with a 52-week drawdown of -27.63%. RSI at 54.19 is neutral.
- lowNews sample totals only 7 articles, which is sparse. Sentiment is 1 positive, 6 neutral, 0 negative — insufficient volume for a reliable directional read.
Cross-section contradictions
- Mean analyst rating of 1.29 across 35 analysts (1–5 scale, lower = more constructive) stands in contrast to a 23.04% price decline over 12 months and a -27.63% drawdown from the 52-week high — sell-side coverage and market price action have diverged materially over the past year.
- FCF was positive in 4 of the tracked years, indicating recurring cash-generation capacity, yet HDFCLIFE ranks last of 6 peers on both quality score (20 vs peer range 23–64) and ROE (11.28% vs peer range 13.15–17.91%).
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.
Fundamentals & technicals: refreshed 25 Jun 2026 · refreshed daily at 01:00 IST
AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 21 Jun 2026 · rotates through NIFTY 500 every ~5 days